Literature DB >> 9171290

Solution structure of R-elafin, a specific inhibitor of elastase.

C Francart1, M Dauchez, A J Alix, G Lippens.   

Abstract

The solution structure of r-elafin, a specific elastase inhibitor, has been determined using NMR spectroscopy. Characterized by a flat core and a flexible N-terminal extremity, the three-dimensional structure is formed by a central twisted beta-hairpin accompanied by two external segments linked by the proteinase binding loop. A cluster of three disulfide bridges connects the external segments to the central beta-sheet and a single fourth disulfide bridge links the binding loop to the central beta-turn. The same spatial distribution of disulfide bridges can be observed in both domains of the secretory leukocyte protease inhibitor (SLPI), another elastase inhibitor. The structural homology between r-elafin and the C-terminal domain of SLPI confirms the former as a second member of the chelonianin family of proteinase inhibitors. Based on the homology between the two proteins and recent results obtained for elastase binding mutants of the bovine pancreatic trypsin inhibitor (BPTI), we define the segment 22 to 27 as the binding loop of elafin, with the scissile peptide bond between Ala24 and Met25. In our solution structures, this loop is extended and solvent-exposed, and exhibits a large degree of flexibility. This mobility, already observed for the binding loop in other protease inhibitors in solution, might be an important feature for the interaction with the corresponding protease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9171290     DOI: 10.1006/jmbi.1997.0983

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  12 in total

Review 1.  The comparative biology of whey proteins.

Authors:  Kaylene J Simpson; Kevin R Nicholas
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-07       Impact factor: 2.673

2.  Functional anthology of intrinsic disorder. 1. Biological processes and functions of proteins with long disordered regions.

Authors:  Hongbo Xie; Slobodan Vucetic; Lilia M Iakoucheva; Christopher J Oldfield; A Keith Dunker; Vladimir N Uversky; Zoran Obradovic
Journal:  J Proteome Res       Date:  2007-03-29       Impact factor: 4.466

3.  Molecular modelling and experimental studies of mutation and cell-adhesion sites in the fibronectin type III and whey acidic protein domains of human anosmin-1.

Authors:  A Robertson; G S MacColl; J A Nash; M K Boehm; S J Perkins; P M Bouloux
Journal:  Biochem J       Date:  2001-08-01       Impact factor: 3.857

Review 4.  The trappin gene family: proteins defined by an N-terminal transglutaminase substrate domain and a C-terminal four-disulphide core.

Authors:  J Schalkwijk; O Wiedow; S Hirose
Journal:  Biochem J       Date:  1999-06-15       Impact factor: 3.857

5.  Functional study of elafin cleaved by Pseudomonas aeruginosa metalloproteinases.

Authors:  Nicolas Guyot; Gudmundur Bergsson; Marcus W Butler; Catherine M Greene; Sinéad Weldon; Efrat Kessler; Rodney L Levine; Shane J O'Neill; Clifford C Taggart; Noel G McElvaney
Journal:  Biol Chem       Date:  2010-06       Impact factor: 3.915

6.  NMR solution structure of Apis mellifera chymotrypsin/cathepsin G inhibitor-1 (AMCI-1): structural similarity with Ascaris protease inhibitors.

Authors:  T Cierpicki; J Bania; J Otlewski
Journal:  Protein Sci       Date:  2000-05       Impact factor: 6.725

7.  Elafin, an elastase-specific inhibitor, is cleaved by its cognate enzyme neutrophil elastase in sputum from individuals with cystic fibrosis.

Authors:  Nicolas Guyot; Marcus W Butler; Paul McNally; Sinead Weldon; Catherine M Greene; Rodney L Levine; Shane J O'Neill; Clifford C Taggart; Noel G McElvaney
Journal:  J Biol Chem       Date:  2008-09-17       Impact factor: 5.157

8.  Elafin is specifically inactivated by RgpB from Porphyromonas gingivalis by distinct proteolytic cleavage.

Authors:  Tomasz Kantyka; Ties Latendorf; Oliver Wiedow; Joachim Bartels; Regine Gläser; Grzegorz Dubin; Jens-Michael Schröder; Jan Potempa; Ulf Meyer-Hoffert
Journal:  Biol Chem       Date:  2009-12       Impact factor: 3.915

9.  Structural and antimicrobial properties of human pre-elafin/trappin-2 and derived peptides against Pseudomonas aeruginosa.

Authors:  Audrey Bellemare; Nathalie Vernoux; Sébastien Morin; Stéphane M Gagné; Yves Bourbonnais
Journal:  BMC Microbiol       Date:  2010-10-08       Impact factor: 3.605

10.  Freezing the Bioactive Conformation to Boost Potency: The Identification of BAY 85-8501, a Selective and Potent Inhibitor of Human Neutrophil Elastase for Pulmonary Diseases.

Authors:  Franz von Nussbaum; Volkhart M-J Li; Swen Allerheiligen; Sonja Anlauf; Lars Bärfacker; Martin Bechem; Martina Delbeck; Mary F Fitzgerald; Michael Gerisch; Heike Gielen-Haertwig; Helmut Haning; Dagmar Karthaus; Dieter Lang; Klemens Lustig; Daniel Meibom; Joachim Mittendorf; Ulrich Rosentreter; Martina Schäfer; Stefan Schäfer; Jens Schamberger; Leila A Telan; Adrian Tersteegen
Journal:  ChemMedChem       Date:  2015-06-17       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.